Charles-Hugo Marquette Institut Hospitalo-Universitaire (IHU), RespirERA Université Côte d'Azur, Hôpital Pasteur, CHU de Nice Biography Publications Institution JoVE Articles Charles-Hugo Marquette has not added a biography. If you are Charles-Hugo Marquette and would like to personalize this page please email our Author Liaison for assistance. Publications The Need to Set Up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte D'Azur, Nice, France) Journal of Personalized Medicine. Jun, 2023 | Pubmed ID: 37511690 [Primary Spontaneous Pneumothorax: We Have Time to Get Some Fresh Air…] Revue Des Maladies Respiratoires. Mar, 2023 | Pubmed ID: 36710208 Circulating Tumour Cells As a Potential Biomarker for Lung Cancer Screening: a Prospective Cohort Study The Lancet. Respiratory Medicine. Jul, 2020 | Pubmed ID: 32649919 Prospective Evaluation of NGS-based Liquid Biopsy in Untreated Late Stage Non-squamous Lung Carcinoma in a Single Institution Journal of Translational Medicine. Feb, 2020 | Pubmed ID: 32066459 A Case Report of Exogenous Lipoid Pneumonia Associated with Avocado/soybean Unsaponifiables BMC Pulmonary Medicine. Dec, 2019 | Pubmed ID: 31795982 Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer? Journal of Clinical Medicine. Mar, 2019 | Pubmed ID: 30917582 [Tumor Banks and Complex Data Management: Current and Future Challenges] Annales De Pathologie. Apr, 2019 | Pubmed ID: 30819623 Circulating Tumor Cell Detection in Lung Cancer: But to What End? Cancers. Feb, 2019 | Pubmed ID: 30813420 The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again Cancers. Feb, 2019 | Pubmed ID: 30795607 Lung Cancer Screening, Towards a Multidimensional Approach: Why and How? Cancers. Feb, 2019 | Pubmed ID: 30759893 Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma Cancers. Sep, 2018 | Pubmed ID: 30216999 Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? Cancers. Jun, 2018 | Pubmed ID: 29966305 Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections Through the Encapsulation of Dried DNA Cancers. Jun, 2018 | Pubmed ID: 29891792 Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients Cancers. Mar, 2018 | Pubmed ID: 29561830 [The Biological Rationale for Immunotherapy in Cancer] Revue Des Maladies Respiratoires. Feb, 2018 | Pubmed ID: 29428191 Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer (Video) | JoVE Christophe Bontoux1,2,3,4,5, Virginie Lespinet-Fabre1,2,3,4, Olivier Bordone1,2,3,4, Virginie Tanga1,2,3,4, Maryline Allegra1,2,3,4, Myriam Salah1,2,3,4, Salomé Lalvée1,2,3,4, Samantha Goffinet1,2,3,4, Jonathan Benzaquen3,4,5,6, Charles-Hugo Marquette3,4,5,6, Marius Ilié1,2,3,4,5, Véronique Hofman1,2,3,4,5, Paul Hofman1,2,3,4,5 1Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, CHU de Nice, 2Hospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 3Institut Hospitalo-Universitaire (IHU), RespirERA, Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 4FHU OncoAge, Université Côte d'Azur, 5Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, 6Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur JoVE 65190 Biologia
Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer (Video) | JoVE Christophe Bontoux1,2,3,4,5, Virginie Lespinet-Fabre1,2,3,4, Olivier Bordone1,2,3,4, Virginie Tanga1,2,3,4, Maryline Allegra1,2,3,4, Myriam Salah1,2,3,4, Salomé Lalvée1,2,3,4, Samantha Goffinet1,2,3,4, Jonathan Benzaquen3,4,5,6, Charles-Hugo Marquette3,4,5,6, Marius Ilié1,2,3,4,5, Véronique Hofman1,2,3,4,5, Paul Hofman1,2,3,4,5 1Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, CHU de Nice, 2Hospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 3Institut Hospitalo-Universitaire (IHU), RespirERA, Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 4FHU OncoAge, Université Côte d'Azur, 5Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, 6Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur JoVE 65190 Biologia